Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ideaya Biosciences Inc (NQ: IDYA ) 29.63 +0.38 (+1.30%) Streaming Delayed Price Updated: 3:11 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ideaya Biosciences Inc < Previous 1 2 3 4 5 Next > Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate September 23, 2024 IDEAYA Biosciences released interim Phase 2 data that shows promising tumor shrinkage and eye preservation rates. Via Benzinga Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday September 10, 2024 Via Benzinga IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 August 06, 2024 IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal August 03, 2024 Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,... Via Talk Markets MarketBeat Week in Review – 7/15 - 7/19 July 20, 2024 Stocks took a breather to close the week, but corporate earnings and the next reading on the PCE index will help determine what direction the market moves next Via MarketBeat Topics Economy Exposures Interest Rates Unveiling 5 Analyst Insights On IDEAYA Biosciences May 08, 2024 Via Benzinga Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews March 08, 2024 Via Benzinga The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts February 21, 2024 Via Benzinga Positive News is Driving This Cancer Drug Maker’s Stock Higher July 15, 2024 IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather Via MarketBeat Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 10, 2024 Via Benzinga Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session July 10, 2024 Via Benzinga Recap: IDEAYA Biosciences Q4 Earnings February 20, 2024 Via Benzinga The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts January 26, 2024 Via Benzinga Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 08, 2024 Via Benzinga IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer July 08, 2024 IDEAYA Biosciences reports promising Phase 2 clinical data for IDE397 in MTAP-deletion urothelial and NSCLC patients. The study shows a 39% overall response rate, 94% disease control rate, and a... Via Benzinga Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday July 08, 2024 Via Benzinga IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24 January 24, 2024 Via Investor Brand Network IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19 January 19, 2024 Via Investor Brand Network Why Ideaya Biosciences Just Made Its Most Bullish Move Since March July 08, 2024 The company is working on a treatment for cancers tied to a genetic alteration called MTAP deletion. Via Investor's Business Daily Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket July 08, 2024 Via Benzinga IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024 May 07, 2024 IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know January 25, 2024 Via Benzinga Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine January 11, 2024 IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using... Via Talk Markets Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know January 10, 2024 Via Benzinga 8 Analysts Have This to Say About IDEAYA Biosciences November 30, 2023 Via Benzinga The Latest Analyst Ratings for IDEAYA Biosciences November 13, 2023 Via Benzinga Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 25, 2023 Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Via Benzinga Why Ideaya Biosciences Stock Is Plummeting Today October 25, 2023 Ideaya stock is getting hit hard following a recent press release from the company. Via The Motley Fool Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session October 25, 2023 Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants. Via Benzinga Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session October 25, 2023 U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.